Roche’s PiaSky approved in the EU for treatment of people with PNH
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Launches Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
The brand will establish an integrated hearing care ecosystem at Neuberg Diagnostics centers across the length and breadth of the country
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
Subscribe To Our Newsletter & Stay Updated